• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 住院患者死亡的预测因素:一项为期 1 年的病例对照研究。

Predictors of mortality in hospitalised patients with COVID-19: a 1-year case-control study.

机构信息

Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia.

Clínica del Occidente, Bogota, Colombia.

出版信息

BMJ Open. 2024 Feb 14;14(2):e072784. doi: 10.1136/bmjopen-2023-072784.

DOI:10.1136/bmjopen-2023-072784
PMID:38355186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10868294/
Abstract

BACKGROUND

A paucity of predictive models assessing risk factors for COVID-19 mortality that extend beyond age and gender in Latino population is evident in the current academic literature.

OBJECTIVES

To determine the associated factors with mortality, in addition to age and sex during the first year of the pandemic.

DESIGN

A case-control study with retrospective revision of clinical and paraclinical variables by systematic revision of clinical records was conducted. Multiple imputations by chained equation were implemented to account for missing variables. Classification and regression trees (CART) were estimated to evaluate the interaction of associated factors on admission and their role in predicting mortality during hospitalisation. No intervention was performed.

SETTING

High-complexity centre above 2640 m above sea level (masl) in Colombia.

PARTICIPANTS

A population sample of 564 patients admitted to the hospital with confirmed COVID-19 by PCR. Deceased patients (n=282) and a control group (n=282), matched by age, sex and month of admission, were included.

MAIN OUTCOME MEASURE

Mortality during hospitalisation.

MAIN RESULTS

After the imputation of datasets, CART analysis estimated 11 clinical profiles based on respiratory distress, haemoglobin, lactate dehydrogenase, partial pressure of oxygen to inspired partial pressure of oxygen ratio, chronic kidney disease, ferritin, creatinine and leucocytes on admission. The accuracy model for prediction was 80.4% (95% CI 71.8% to 87.3%), with an area under the curve of 78.8% (95% CI 69.63% to 87.93%).

CONCLUSIONS

This study discloses new interactions between clinical and paraclinical features beyond age and sex influencing mortality in COVID-19 patients. Furthermore, the predictive model could offer new clues for the personalised management of this condition in clinical settings.

摘要

背景

在当前的学术文献中,明显缺乏能够预测拉丁裔人群 COVID-19 死亡率的风险因素的预测模型,这些模型不仅限于年龄和性别。

目的

确定除年龄和性别以外,在大流行的第一年与死亡率相关的因素。

设计

这是一项病例对照研究,通过系统地审查临床记录对临床和临床前变量进行回顾性修订。采用链式方程进行多重插补,以解决缺失变量的问题。采用分类回归树(CART)评估入院时相关因素的相互作用及其在预测住院期间死亡率中的作用。未进行任何干预。

地点

哥伦比亚海拔 2640 米以上的高复杂度中心。

参与者

该研究纳入了一个由 564 名经 PCR 确诊为 COVID-19 的住院患者组成的人群样本。包括死亡患者(n=282)和对照组(n=282),按年龄、性别和入院月份匹配。

主要观察指标

住院期间的死亡率。

主要结果

在数据集的插补后,CART 分析根据入院时的呼吸窘迫、血红蛋白、乳酸脱氢酶、氧分压与吸入氧分压比、慢性肾脏病、铁蛋白、肌酐和白细胞估计了 11 个临床特征。预测准确率模型为 80.4%(95%CI 71.8%至 87.3%),曲线下面积为 78.8%(95%CI 69.63%至 87.93%)。

结论

这项研究揭示了除年龄和性别以外,影响 COVID-19 患者死亡率的临床和临床前特征之间的新的相互作用。此外,该预测模型可为临床环境中该疾病的个体化管理提供新的线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08a4/10868294/15ffcacf5867/bmjopen-2023-072784f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08a4/10868294/ad1a307360c4/bmjopen-2023-072784f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08a4/10868294/15ffcacf5867/bmjopen-2023-072784f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08a4/10868294/ad1a307360c4/bmjopen-2023-072784f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08a4/10868294/15ffcacf5867/bmjopen-2023-072784f02.jpg

相似文献

1
Predictors of mortality in hospitalised patients with COVID-19: a 1-year case-control study.COVID-19 住院患者死亡的预测因素:一项为期 1 年的病例对照研究。
BMJ Open. 2024 Feb 14;14(2):e072784. doi: 10.1136/bmjopen-2023-072784.
2
Prediction model for in-hospital mortality in patients at high altitudes with ARDS due to COVID-19.预测 COVID-19 导致高原地区 ARDS 患者院内死亡率的模型。
PLoS One. 2023 Oct 26;18(10):e0293476. doi: 10.1371/journal.pone.0293476. eCollection 2023.
3
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
4
Clinical characteristics and mortality associated with COVID-19 at high altitude: a cohort of 5161 patients in Bogotá, Colombia.高海拔地区与新冠病毒病相关的临床特征及死亡率:哥伦比亚波哥大5161例患者队列研究
Int J Emerg Med. 2022 May 21;15(1):22. doi: 10.1186/s12245-022-00426-4.
5
Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.新型冠状病毒肺炎患者的急性肾损伤:城市内医院的经验及政策影响。
Am J Nephrol. 2020;51(10):786-796. doi: 10.1159/000511160. Epub 2020 Oct 2.
6
Remdesivir for the treatment of COVID-19.瑞德西韦治疗 COVID-19。
Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014962. doi: 10.1002/14651858.CD014962.pub2.
7
Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score.开发和验证一种预测模型,用于预测 COVID-19 住院患者 30 天死亡率:COVID-19 SEIMC 评分。
Thorax. 2021 Sep;76(9):920-929. doi: 10.1136/thoraxjnl-2020-216001. Epub 2021 Feb 25.
8
Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.皮下注射沙利鲁单抗治疗中重度 COVID-19 感染住院患者与标准治疗(SARCOVID)的比较:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Sep 9;21(1):772. doi: 10.1186/s13063-020-04588-5.
9
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.挪威 2019 年冠状病毒病(NO COVID-19)实用开放性标签研究,评估硫酸羟氯喹在 2019 年冠状病毒病中度重症住院患者中的早期使用:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.
10
Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.2020年2月至8月第一波疫情期间瑞士住院的COVID-19患者出现严重后果的风险因素:前瞻性观察队列研究。
Swiss Med Wkly. 2021 Jul 28;151:w20547. doi: 10.4414/smw.2021.20547. eCollection 2021 Jul 19.

引用本文的文献

1
Pregnancy and COVID-19: Comparing ICU Outcomes for Pregnant and Nonpregnant Women.妊娠与新冠病毒病:比较孕妇和非孕妇在重症监护病房的治疗结果
Viruses. 2024 Dec 31;17(1):51. doi: 10.3390/v17010051.
2
Predictors of 2-year mortality in geriatric patients hospitalized with COVID-19 in Türkiye: a retrospective cohort study.土耳其老年 COVID-19 住院患者 2 年死亡率的预测因素:一项回顾性队列研究。
Biomark Med. 2024;18(10-12):555-565. doi: 10.1080/17520363.2024.2352416. Epub 2024 Aug 14.

本文引用的文献

1
Clinical profile and severity predictors of coronavirus disease 19 infection in a reference center from southern Brazil: a cross-sectional study.巴西南部一家参考中心的 2019 冠状病毒病感染的临床特征和严重程度预测因素:一项横断面研究。
Rev Assoc Med Bras (1992). 2023 Apr 14;69(4):e20221271. doi: 10.1590/1806-9282.20221271. eCollection 2023.
2
Predicting Risk of Mortality in COVID-19 Hospitalized Patients using Hybrid Machine Learning Algorithms.使用混合机器学习算法预测新冠肺炎住院患者的死亡风险
J Biomed Phys Eng. 2022 Dec 1;12(6):611-626. doi: 10.31661/jbpe.v0i0.2105-1334. eCollection 2022 Dec.
3
Construction of a nomogram for predicting COVID-19 in-hospital mortality: A machine learning analysis.
构建用于预测COVID-19院内死亡率的列线图:机器学习分析
Inform Med Unlocked. 2023;36:101138. doi: 10.1016/j.imu.2022.101138. Epub 2022 Dec 2.
4
Identification of hospitalized mortality of patients with COVID-19 by machine learning models based on blood inflammatory cytokines.基于血液炎症细胞因子的机器学习模型对 COVID-19 住院患者病死率的识别。
Front Public Health. 2022 Nov 17;10:1001340. doi: 10.3389/fpubh.2022.1001340. eCollection 2022.
5
Machine learning-based scoring system to predict in-hospital outcomes in patients hospitalized with COVID-19.基于机器学习的评分系统,用于预测因 COVID-19 住院的患者的院内结局。
Arch Cardiovasc Dis. 2022 Dec;115(12):617-626. doi: 10.1016/j.acvd.2022.08.003. Epub 2022 Oct 22.
6
Machine learning-based derivation and external validation of a tool to predict death and development of organ failure in hospitalized patients with COVID-19.基于机器学习的工具的推导和外部验证,用于预测住院 COVID-19 患者的死亡和器官衰竭的发展。
Sci Rep. 2022 Oct 8;12(1):16913. doi: 10.1038/s41598-022-20724-4.
7
Inflammatory Biomarkers Associated with In-Hospital Mortality in Critical COVID-19 Patients.与重症 COVID-19 患者住院期间死亡率相关的炎症生物标志物。
Int J Mol Sci. 2022 Sep 9;23(18):10423. doi: 10.3390/ijms231810423.
8
Machine-learning-derived predictive score for early estimation of COVID-19 mortality risk in hospitalized patients.基于机器学习的预测评分模型,用于早期评估住院患者 COVID-19 死亡风险。
PLoS One. 2022 Sep 22;17(9):e0274171. doi: 10.1371/journal.pone.0274171. eCollection 2022.
9
A comparison of machine learning algorithms in predicting COVID-19 prognostics.机器学习算法在预测 COVID-19 预后中的比较。
Intern Emerg Med. 2023 Jan;18(1):229-239. doi: 10.1007/s11739-022-03101-x. Epub 2022 Sep 18.
10
The Associations of Iron Related Biomarkers with Risk, Clinical Severity and Mortality in SARS-CoV-2 Patients: A Meta-Analysis.铁相关生物标志物与 SARS-CoV-2 患者风险、临床严重程度和死亡率的关联:一项荟萃分析。
Nutrients. 2022 Aug 19;14(16):3406. doi: 10.3390/nu14163406.